solifenacin succinate has been researched along with Cognition Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Betz, D; Burger, M; Hampel, C; Nowak, C; Vogel, M | 1 |
| Bolodeoku, J; Edgar, C; Tretter, RN; Wesnes, KA | 1 |
| Jakobsen, SM; Kersten, H; Molden, E | 1 |
1 trial(s) available for solifenacin succinate and Cognition Disorders
| Article | Year |
|---|---|
Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg.
Topics: Aged; Attention; Cognition; Cognition Disorders; Cross-Over Studies; Executive Function; Female; Humans; Hypnotics and Sedatives; Learning; Male; Mandelic Acids; Memory; Memory, Short-Term; Muscarinic Antagonists; Neuropsychological Tests; Parasympatholytics; Pilot Projects; Quinuclidines; Reaction Time; Risk; Sample Size; Solifenacin Succinate; Tetrahydroisoquinolines | 2009 |
2 other study(ies) available for solifenacin succinate and Cognition Disorders
| Article | Year |
|---|---|
Solifenacin in the Elderly: Results of an Observational Study Measuring Efficacy, Tolerability and Cognitive Effects.
Topics: Aged; Aged, 80 and over; Cognition; Cognition Disorders; Female; Germany; Humans; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive | 2017 |
Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay.
Topics: Benzhydryl Compounds; Benzofurans; Biological Assay; Brain; Cognition Disorders; Cresols; Humans; In Vitro Techniques; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate | 2011 |